CISplatin
Approved
Approval ID
be185d9c-d82f-442b-81db-348e3715e7a4
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 21, 2023
Manufacturers
FDA
Apotex Corp.
DUNS: 845263701
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CISplatin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code60505-6277
Product Classification
G
Generic Name
CISplatin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 21, 2023
FDA Product Classification
INGREDIENTS (5)
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
CISPLATINActive
Quantity: 50 mg in 50 mL
Code: Q20Q21Q62J
Classification: ACTIB